Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;36(1):83-88.
doi: 10.1016/j.bpa.2022.02.006. Epub 2022 Apr 10.

Post-cesarean section analgesia

Ellen Veef  1 , Marc Van de Velde  2
Affiliations
Review

Post-cesarean section analgesia

Ellen Veef et al. Best Pract Res Clin Anaesthesiol. 2022 May.

Abstract

Worldwide, the most performed surgical intervention is cesarean section. Hence, post-cesarean pain is a common problem with significant health and economic impact on the individual patient and society. Adequate treatment of post-cesarean pain is necessary to facilitate enhanced recovery, improve neonatal outcome by improving breastfeeding success and bonding between mother and child, and reduce pain-induced side effects. Therefore, optimal pain relief is important, but in the obstetric population, this is often complex due to the interplay of mother and neonate. To facilitate recovery and temper the side effects of potent analgesic drugs such as opioids, multimodal analgesia is currently advocated, and clear international guidelines and recommendations have recently been described. In the present overview, we will discuss the most recent guidelines and evaluate various analgesic interventions.

Keywords: PROSPECT; cesarean section; dexamethasone; enhanced recovery after C-section (ERAC); multimodal analgesia; post-cesarean analgesia.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Ellen Veef has no conflicts of interest to declare. In the last three years, Marc Van de Velde has received honoraria from CSL Behring, Vifor Pharma, Aspen, MSD, Nordic Pharma, Heron Therapeutics, Werfen, and Aquettant. Marc Van de Velde is Editor-in-Chief of Best Research and Practice in Clinical Anaesthesiology, Deputy Editor-in-Chief of the European Journal of Anaesthesiology, The European Journal of Anaesthesiology and Intensive Care, and the Acta Anaesthesiologica Belgica.

Similar articles

See all similar articles

Cited by

LinkOut - more resources